Debra Odink

2013

In 2013, Debra Odink earned a total compensation of $1M as Chief Technology Officer at Anthera Pharmaceuticals, a 90% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$24,276
Option Awards$648,305
Salary$340,000
Stock Awards$31,693
Total$1,044,274

Odink received $648.3K in option awards, accounting for 62% of the total pay in 2013.

Odink also received $24.3K in non-equity incentive plan, $340K in salary and $31.7K in stock awards.

Rankings

In 2013, Debra Odink's compensation ranked 6,404th out of 12,286 executives tracked by ExecPay. In other words, Odink earned more than 47.9% of executives.

ClassificationRankingPercentile
All
6,404
out of 12,286
48th
Division
Manufacturing
2,245
out of 4,612
51st
Major group
Chemicals And Allied Products
668
out of 1,462
54th
Industry group
Drugs
484
out of 1,156
58th
Industry
Pharmaceutical Preparations
386
out of 890
57th
Source: SEC filing on April 9, 2015.

Odink's colleagues

We found four more compensation records of executives who worked with Debra Odink at Anthera Pharmaceuticals in 2013.

2013

Paul Truex

Anthera Pharmaceuticals

Chief Executive Officer

2013

Colin Hislop

Anthera Pharmaceuticals

Chief Medical Officer

2013

Christopher Lowe

Anthera Pharmaceuticals

Chief Financial Officer

2013

May Liu

Anthera Pharmaceuticals

Senior Vice President, Finance & Administration

In-depth

You may also like